Use changes after recreational marijuana legalization

November 13, 2019

Bottom Line: How the legalization of recreational marijuana in some states was associated with changes in marijuana use and cannabis use disorder compared to other states from 2008 to 2016 was the focus of this study. Researchers used national survey data from nearly 506,000 participants in age groups from 12 to 17, 18 to 25, and 26 or older. The authors report that after the legalization of recreational marijuana, the proportion of respondents 12 to 17 reporting past-year cannabis use disorder increased from 2.18% to 2.72%. Also, the proportion of respondents 26 or older reporting frequent marijuana use increased from 2.13% to 2.62% and those reporting cannabis use disorder increased from 0.90% to 1.23%. No associations were found among those respondents 18 to 25. A limitation of the study is its reliance on self-reported marijuana use. The increases in use and risk of cannabis use disorder observed in this study are potential public health concerns.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Authors: Magdalena Cerdá, Dr.P.H., of the New York University School of Medicine, New York, and coauthors.

(doi:10.1001/jamapsychiatry.2019.3254)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Media advisory: To contact corresponding author Magdalena Cerdá, Dr.P.H., email Sasha Walek at Sasha.Walek@nyulangone.org. The full study, editorial and podcast are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2019.3254?guestAccessKey=3cd6baa3-b7f9-44f4-81bb-ea005c929794&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111319

JAMA Psychiatry

Related Cannabis Articles from Brightsurf:

Cannabis to treat gynecological conditions
A significant number of women would consider using cannabis to treat gynecological conditions, primarily gynecological pain.

Cannabis data lacking, but machine learning could help
Everyone's heard of THC and CBD. But many other active compounds in cannabis interact to influence its effects.

Cannabis use for menopause symptom management
CLEVELAND, Ohio (September 28, 2020)--As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms.

Prescribed CBD could help people quit cannabis
A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.

Pregnant women with depression are more than 3 times more likely to use cannabis
Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression.

Cannabis compound acts as an antibiotic 
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

Managing cannabis use in breastfeeding women
As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern.

Cannabis edibles present novel health risks
With the recent legalization of cannabis edibles in Canada, physicians and the public must be aware of the novel risks of cannabis edibles, argue authors in a commentary in CMAJ (Canadian Medical Association Journal).

Read More: Cannabis News and Cannabis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.